Vireo Growth VREOF
OTC VREOF
$10.71 -0.26 (-2.37%)
At close: Aug 20, 2026 · 4:00 PM EDT

Vireo Growth (VREOF) EPS (Diluted) Growth (5y) (2025 - 2026)

Vireo Growth (VREOF) EPS (Diluted) Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Vireo Growth 490.54 Mn 348.24 Mn 95.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.41%
Dec 31, 2025 -7.47%
Sep 30, 2025 -42.56%
Jun 30, 2025 15.33%